Locoregional Stomach Cancer

Stomach Adenocarcinoma

Female, 67 years

Patient Internal ID: 500412336

ICD-10 code

C16.8 Malignant Neoplasm of Overlapping Sites of Stomach

Diagnosis (Incl. Metastases/Stage) and Year

November 2020
Stomach Adenocarcinoma T4N3(22/26)M1 R0, R0 HER2(-), MMRp

Previous Treatment

Chemotherapy (Neoadjuvant FLOT), Surgery (Total Gastrectomy).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~13 months from diagnosis.

Treatment Provided

Autologous DCV (5 doses) and CIK (4 doses) over a period of 4 months.

Patient Survival/Condition and Year
Date of Review: 06/11/2023

The patient has survived for over 29 months from diagnosis. According to Tumor Board, the decision was not to prescribe Adjuvant Chemotherapy, as little response was observed during Neoadjuvant Chemotherapy. It can be concluded that the addition of Immunotherapy, together with Surgery and Chemotherapy, extended patient survival by an estimate of 16 months.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok